{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:49:42Z","timestamp":1793998182922,"version":"4.8.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007352","name":"Staatssekretariat f\u00fcr Bildung, Forschung und Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["110617"],"award-info":[{"award-number":["110617"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["107957"],"award-info":[{"award-number":["107957"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.annonc.2023.11.014","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:14:00Z","timestamp":1701800040000},"page":"276-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin\u2019s lymphoma: results from the randomized international GHSG HD18 trial"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3481-7997","authenticated-orcid":false,"given":"J.","family":"Ferdinandus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Damaschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Krasniqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Mey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sch\u00f6ndube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thiemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mathas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Greil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Feuring-Buske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8633-4789","authenticated-orcid":false,"given":"J.","family":"Markova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.U.","family":"R\u00fcffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-T.","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Baues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Borchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Behringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annonc.2023.11.014_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.1999.17.1.253","article-title":"Hodgkin\u2019s disease survivors more fatigued than the general population","volume":"17","author":"Loge","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib2","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S1470-2045(16)30093-6","article-title":"Cancer-related fatigue in patients with and survivors of Hodgkin\u2019s lymphoma: a longitudinal study of the German Hodgkin Study Group","volume":"17","author":"Kreissl","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib3","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1200\/JCO.2016.67.7450","article-title":"Cancer-related fatigue in patients with and survivors of Hodgkin lymphoma: the impact on treatment outcome and social reintegration","volume":"34","author":"Behringer","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib4","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","article-title":"PET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group","volume":"390","author":"Borchmann","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2023.11.014_bib5","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1016\/S2352-3026(21)00101-0","article-title":"PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial","volume":"8","author":"Kreissl","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.annonc.2023.11.014_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1470-2045(17)30103-1","volume":"18","author":"Borchmann","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.annonc.2023.11.014_bib8","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0959-8049(03)00545-8","article-title":"Fatigue in long-term survivors of Hodgkin\u2019s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)","volume":"39","author":"JU","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annonc.2023.11.014_bib9","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(19)30790-9","article-title":"International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium","volume":"21","author":"Coens","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.annonc.2023.11.014_bib11","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1200\/JCO.19.03160","article-title":"Health-related quality of life in patients with Hodgkin lymphoma: a longitudinal analysis of the German Hodgkin Study Group","volume":"38","author":"Kreissl","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.annonc.2023.11.014_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/0284186X.2023.2195561","article-title":"Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials","volume":"62","author":"Juul","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11764-015-0436-0","article-title":"Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study","volume":"9","author":"Glimelius","year":"2015","journal-title":"J\u00a0Cancer Surviv"},{"key":"10.1016\/j.annonc.2023.11.014_bib15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s10880-023-09944-6","article-title":"Web-based cognitive-behavioral therapy to reduce severe cancer-related fatigue among survivors of Hodgkin lymphoma: a feasibility study","volume":"30","author":"Esser","year":"2023","journal-title":"J\u00a0Clin Psychol Med Settings"},{"key":"10.1016\/j.annonc.2023.11.014_bib16","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1200\/JCO.2006.06.8270","article-title":"Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial","volume":"24","author":"Gielissen","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1037\/a0012825","article-title":"Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients","volume":"134","author":"Kangas","year":"2008","journal-title":"Psychol Bull"},{"key":"10.1016\/j.annonc.2023.11.014_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.annonc.2019.09.002","article-title":"Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial","volume":"31","author":"Poort","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib19","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1200\/JCO.2011.39.6333","article-title":"Impact of cancer on work and education among adolescent and young adult cancer survivors","volume":"30","author":"Parsons","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/bjc.2013.779","article-title":"Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity","volume":"110","author":"Daniels","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annonc.2023.11.014_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejca.2017.06.025","article-title":"A\u00a0systematic review of the quality of statistical methods employed for analysing quality of life data in cancer randomised controlled trials","volume":"83","author":"Hamel","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annonc.2023.11.014_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa1708984","article-title":"Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin\u2019s lymphoma","volume":"378","author":"Connors","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annonc.2023.11.014_bib23","doi-asserted-by":"crossref","first-page":"TPS8067","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS8067","article-title":"An intergroup collaboration for advanced stage classical Hodgkin lymphoma (cHL) in adolescents and young adults (AYA): SWOG S1826","volume":"38","author":"Castellino","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.annonc.2023.11.014_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw273","article-title":"International psychometric validation of an EORTC quality of life module measuring cancer related fatigue (EORTC QLQ-FA12)","volume":"109","author":"Weis","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753423051025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753423051025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:59:09Z","timestamp":1777582749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753423051025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0923753423051025"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2023.11.014","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin\u2019s lymphoma: results from the randomized international GHSG HD18 trial","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2023.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}]}}